Newron Pharmaceuticals SpA (XTER:NP5) Other Long Term Assets : €4.52 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Other Long Term Assets?

Newron Pharmaceuticals SpA's other long-term assets for the quarter that ended in Jun. 2024 was €4.52 Mil.

Newron Pharmaceuticals SpA's quarterly other long-term assets declined from Jun. 2023 (€6.78 Mil) to Dec. 2023 (€5.81 Mil) but then stayed the same from Dec. 2023 (€5.81 Mil) to Jun. 2024 (€4.52 Mil).

Newron Pharmaceuticals SpA's annual other long-term assets declined from Dec. 2021 (€10.48 Mil) to Dec. 2022 (€8.18 Mil) and declined from Dec. 2022 (€8.18 Mil) to Dec. 2023 (€5.81 Mil).

Newron Pharmaceuticals SpA Other Long Term Assets Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Other Long Term Assets Chart

Newron Pharmaceuticals SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

14.53

12.58

10.48

8.18

5.81

Newron Pharmaceuticals SpA Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Long Term Assets	Get a 7-Day Free Trial															9.12	8.18	6.78	5.81	4.52

Newron Pharmaceuticals SpA Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Newron Pharmaceuticals SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NWPHF:USA 0QOI:UK NWRN:Switzerland

Address

Via Antonio Meucci 3, Bresso, Milan, ITA, 20091

Website

https://www.newron.com

Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Executives

Stefan Weber	Board of Directors
Dr. Ulrich Köstlin	Supervisory Board

Newron Pharmaceuticals SpA Headlines

No Headlines